1. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review 
Felix Ratjen, Florian Brockhaus, Gerhild Angyalosi 
Journal of Cystic Fibrosis 
Volume 8, Issue 6, Pages (December 2009)
DOI: /j.jcf
Copyright © 2009 Elsevier B.V. Terms and Conditions

2. Fig. 1
The rationale of using inhaled tobramycin: mean sputum tobramycin concentrations after intravenous tobramycin 80mg/m2 three times daily (approximately 6–10.8mg/kg/day) for 18–21days in four patients with CF [71] and after inhaled tobramycin 300mg/5ml twice daily with PARI LC Plus for three 28-day on/28-day off treatment cycles in 247 patients with CF [72].
Journal of Cystic Fibrosis 2009 8, DOI: ( /j.jcf )
Copyright © 2009 Elsevier B.V. Terms and Conditions